APC and malignant colon neoplasm: However, only 5.5% of colon cancers have mutations both in APC and RNF43, suggesting a differential mechanism of optimal activation of Wnt signaling in gastric and colon cancers for tumor growth and progression (Albuquerque et al., 2002).